Optimizing Patient Usability Experience for Chronic Care

Status Not yet recruiting

Clinical Trial Summary

The study aims to develop a module of an eHealth platform, do a feasibility study through a pilot cluster randomized control trial and assess the scalability of the solution.

Clinical Trial Description

Multimorbidity increases care needs and primary care use among people with chronic diseases (1). The Concerto Health Program (CHP) has been developed to optimize chronic disease management in primary care services. However, in its current version, the CHP primarily targets clinicians and does not aim to respond directly to the needs of patients and their informal caregivers for chronic disease management . This project aims to develop, implement and evaluate a user-centered, multifunctional and personalized eHealth platform (CONCERTO+) to promote a more active patient role in chronic disease management and decision-making through three phases.

For phase1: A first prototype will be developed by the design and technology teams, in close collaboration with researchers, health professionals and patient representatives who will identify the functionalities to include in the CONCERTO+ solution.

The Phase 2 of the project will consist in a feasibility study based on a pilot cluster randomized clinical trial (c-RCT) where patients with chronic diseases from a primary healthcare practice will receive CONCERTO+ and be compared to patients from a control practice receiving usual care.

For Phase 3, the analysis of CONCERTO+ potential for scaling-up will be done by documenting factors and conditions associated with the sustainability and scaling-up of the solution. To do so, the investigators will conduct: 1) two focus groups with patients and informal caregivers who participated in the study (one with the experimental group and one with the control group, each group gathering between eight and twelve participants); 2) semi-structured individual interviews with health professionals at the two study sites, as well as with health care managers, information officers, and representatives of the Ministry of Health and Social Services. ;

Study Design

Related Conditions & MeSH terms

Chronic Disease

Clinical Trial Details

NCT number	NCT03628963
Study type	Interventional
Source	Laval University
Contact	Marie-Pierre Gagnon, Ph.D
Phone	418 525 4444
Email	marie-pierre.gagnon@fsi.ulaval.ca
Status	Not yet recruiting
Phase	N/A
Start date	September 2018
Completion date	November 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03153644` - Improving Contraceptive Care for Women With Medical Conditions
Recruiting	`NCT06058754` - Group-based [ADAPT] Versus One-to-one [Usual] Occupational Therapy (Go:OT Trial)	N/A
Completed	`NCT04082585` - Total Health Improvement Program Research Project
Recruiting	`NCT05558085` - Biomarker Cost-Benefit Analysis of EFNEP	N/A
Completed	`NCT04037436` - Functional Exercise and Nutrition Education Program for Older Adults	N/A
Not yet recruiting	`NCT05622422` - A Chronic Disease Self Care Management Pilot Study	N/A
Not yet recruiting	`NCT06016101` - Usefulness of the Medissimo Nurse Application for Supporting Medication Compliance in Elderly People With Chronic Polypathologies
Not yet recruiting	`NCT04954209` - Comparative Study in Long-term Commitment to Physical Activity After Two Different Resumption Programs
Not yet recruiting	`NCT04090593` - Chronic Disease Mobile Educational Experience	N/A
Completed	`NCT02390570` - Incorporating Patient Capacity Into the Clinical Landscape	N/A
Completed	`NCT02072941` - Preparing Spanish-speaking Older Adults for Advance Care Planning and Medical Decision Making (PREPARE)	N/A
Completed	`NCT02292940` - Consumer Health IT Tools: Impact on Experience, Access, and Outcomes for Patients With Complex Chronic Conditions
Completed	`NCT02017262` - Group Self-Management of Depression and Medical Illness	N/A
Completed	`NCT01933789` - Improving Communication About Serious Illness	N/A
Terminated	`NCT02115971` - Jumping Exercises Approach in Individuals With Chronic Ankle Instability	N/A
Completed	`NCT02307929` - Evaluation of Quality of Care - Nurse Allied Health Clinic Programme, HA	N/A
Completed	`NCT01458184` - Study of PhoneCare System to Treat Patients With Chronic Diseases	N/A
Completed	`NCT00333710` - Evaluating a Telehealth Treatment for Veterans With Hepatitis C and PTSD	N/A
Completed	`NCT00380536` - Medical Self-Management for Improving Health Behavior Among Individuals in Community Mental Health Settings	N/A
No longer available	`NCT00096811` - Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.